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Eliézer K. N’Goran1,2 and Jürg Utzinger3,4*Abstract
Background: To achieve a world free of schistosomiasis, the objective is to scale up control and elimination efforts in
all endemic countries. Where interruption of transmission is considered feasible, countries are encouraged to
implement a comprehensive intervention package, including preventive chemotherapy, information, education and
communication (IEC), water, sanitation and hygiene (WASH), and snail control. In northern and central Côte d’Ivoire,
transmission of Schistosoma haematobium is seasonal and elimination might be achieved. In a cluster-randomised trial,
we will assess different treatment schemes to interrupt S. haematobium transmission and control soil-transmitted
helminthiasis over a 3-year period. We will compare the impact of (i) arm A: annual mass drug administration (MDA)
with praziquantel and albendazole before the peak schistosomiasis transmission season; (ii) arm B: annual MDA after
the peak schistosomiasis transmission season; (iii) arm C: two yearly treatments before and after peak schistosomiasis
transmission; and (iv) arm D: annual MDA before peak schistosomiasis transmission, coupled with chemical snail control
using niclosamide.
Methods/design: The prevalence and intensity of S. haematobium and soil-transmitted helminth infections will be
assessed using urine filtration and Kato-Katz thick smears, respectively, in six administrative regions in northern and
central parts of Côte d’Ivoire. Once a year, urine and stool samples will be collected and examined from 50 children
aged 5–8 years, 100 children aged 9–12 years and 50 adults aged 20–55 years in each of 60 selected villages. Changes
in S. haematobium and soil-transmitted helminth prevalence and intensity will be assessed between years and stratified
by intervention arm. In the 15 villages randomly assigned to intervention arm D, intermediate host snails will be
collected three times per year, before niclosamide is applied to the selected freshwater bodies. The snail abundance
and infection rates over time will allow drawing inference on the force of transmission.
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Discussion: This cluster-randomised intervention trial will elucidate whether in an area with seasonal transmission, the
four different treatment schemes can interrupt S. haematobium transmission and control soil-transmitted helminthiasis.
Lessons learned will help to guide schistosomiasis control and elimination programmes elsewhere in Africa.
Trial registration: ISRCTN ISRCTN10926858. Registered 21 December 2016. Retrospectively registered.
Keywords: Bulinus spp., Chemical snail control, Côte d’Ivoire, Mass drug administration, Niclosamide, Praziquantel,
Schistosoma haematobium, Seasonal transmission, Soil-transmitted helminthiasisBackground
Burden and transmission of schistosomiasis and
soil-transmitted helminthiasis
More than a billion people are affected by schistosomia-
sis and soil-transmitted helminthiasis worldwide [1]. An
estimated 300 million people with heavy parasitic worm
infections have measurable morbidity, among them,
more than 50% are school-aged children [2, 3]. In 2013,
the global burden due to schistosomiasis and soil-
transmitted helminthiasis was estimated at 7.09 million
disability-adjusted life years (DALYs) [4].
Schistosomiasis is a water-associated disease caused by
chronic infection with parasitic trematodes of the genus
Schistosoma. The life cycle of these blood-dwelling
flukes involves a definitive human host, in which adult
schistosome worms live in the perivesical or mesenteric
venous plexus of their human host. These worms live as
couples and sexually reproduce and shed eggs. Specific
freshwater snails are infested by miracidia hatched from
the eggs of adult worms and the snails act as intermediate
host, in which asexual multiplication of the parasite takes
place and from which infectious larval stages (cercaria),
are shed into water. Infection occurs when humans make
contact with freshwater bodies harbouring these cercaria
[5]. The disease schistosomiasis is caused primarily by in-
flammatory reactions due to the deposition of schistosome
eggs trapped in tissues surrounding the bladder or intes-
tines. Urogenital schistosomiasis, in which the bladder,
genital tract and urethras are affected, is caused by infec-
tion with the species S. haematobium, which occurs
mainly in Africa.
Soil-transmitted helminthiasis is caused by a group of
intestinal nematode worms, the most important of
which are the anthropophilic hookworm (Ancylostoma
duodenale and Necator americanus), roundworm
(Ascaris lumbricoides) and whipworm (Trichuris trichiura).
The life cycles of hookworm, A. lumbricoides and
T. trichiura follow a general pattern. The adult parasite
stages inhabit the gastrointestinal tract, reproduce sexually
and produce eggs, which are passed in human faeces and
are deposited in the external environment. Larval stages
hatch from the eggs either in the soil (hookworm) or in
the intestines after ingestion of food or water contami-
nated with eggs (A. lumbricoides and T. trichiura). Toreach the adult stage, the larvae can migrate into the hu-
man body (after passing through the skin or the digestive
mucosa) and return to the intestine (A. lumbricoides or
hookworm) or remain there (T. trichiura) [6]. Clinical
complications are mainly related to the chronic and
insidious effects on the hosts’ health and nutritional
status [7]. Hookworm infections have long been recog-
nised as an important cause of intestinal blood loss
leading to iron deficiency and protein malnutrition. In-
deed, iron deficiency anaemia accompanying moderate
and heavy hookworm burdens is sometimes referred
to as “hookworm disease” [8]. Chronic soil-transmitted
helminth infections impact the physical and mental
development of children [9].
S. haematobium and soil-transmitted helminth infections
in Côte d’Ivoire
A number of important points regarding the epidemiology
and ecology of schistosomiasis and soil-transmitted hel-
minthiasis are worth highlighting for the northern and
central parts of Côte d’Ivoire. First, S. haematobium is the
predominant Schistosoma species [10–12]. Historical data
and recent empiric studies revealed a low to moderate
prevalence of urogenital schistosomiasis in northern and
central Côte d’Ivoire, with a S. haematobium prevalence
rarely found in excess of 10% among school-aged children
[13–17] (Fig. 1). Preliminary data obtained in early 2014
during a rapid appraisal mapping done by our group in
two regions (Bounkani and Tchologo) in northern Côte
d’Ivoire revealed a prevalence of 3.3–26.7% for S. haema-
tobium and 3.3% for S. mansoni [15].
Two species of freshwater snails (Bulinus truncatus
and B. globosus) transmit urogenital schistosomiasis in
Côte d’Ivoire [10–12]. In the northern part of Côte
d’Ivoire, the major intermediate host snail for S. hae-
matobium is B. truncatus, whereas both snail species
are involved in transmission in the central part of the
country. Due to two distinct seasons, with rainfall oc-
curring between March and October and the dry
period lasting from November to March, there is a
strong seasonality in the presence of snails and schis-
tosomiasis transmission [11] (Fig. 2a and b). The
abundance of S. haematobium-infected intermediate
host snails is strongly driven by this seasonality.
Fig. 1 Map of Côte d’Ivoire, showing geo-referenced S. haematobium prevalence survey data. Source: Global Neglected Tropical Diseases database,
www.gntd.org [16]. The districts included into the study are highlighted in grey in the central part and with grey hachures in the northern part of
Côte d’Ivoire
Tian-Bi et al. BMC Public Health  (2018) 18:186 Page 3 of 12Indeed, infected snails have exclusively been identified
during the dry season (January and February) in man-
made stagnant freshwater bodies [11, 18] (Fig. 2c).
Soil-transmitted helminths are in general more widely
distributed in Côte d’Ivoire and transmitted throughout
the year. In a recent national survey among school-aged
children, the prevalence of hookworm, A. lumbricoides and
T. trichiura was 17.2%, 1.9% and 1.3%, respectively [15].
Control of schistosomiasis and soil-transmitted
helminthiasis in Côte d’Ivoire
The life cycle of S. haematobium can be interrupted by:
(i) killing the worms in humans, using anthelminthic
drugs; (ii) killing the intermediate host snails using che-
micals (i.e. molluscicides), biological control agents (e.g.
competitor snails, fish and prawns) or environmental
management (e.g. draining of swamps); (iii) sensitizing
people not to urinate into open freshwater bodies so that
intermediate host snails cannot become infected; and
(iv) keeping people out of infested water bodies to avoid
infection of humans with cercaria [18–21].
The global strategy to control schistosomiasis is based
on morbidity control through preventive chemotherapy
that is the periodic administration of praziquantel to at-
risk populations (e.g. school-aged children) without prior
individual diagnosis [22]. In Côte d’Ivoire, there is a his-
tory of focal control interventions that were implemented
in the southern, central and western regions, starting in
the 1990s [23]. Thereafter, Côte d’Ivoire has gone through
a decade of socio-political crisis that has degraded thehealth system, as well as control interventions targeting
schistosomiasis and other neglected tropical diseases [24].
In late 2010, the managers of six neglected tropical dis-
eases control programmes developed a 5-year integrated
operational plan, readily assisted by experts from the
World Health Organization (WHO). These control pro-
grammes include (i) the national control programme for
schistosomiasis, soil-transmitted helminthiasis and lymph-
atic filariasis and (ii) the national programme for eye
health and control of onchocerciasis. The 5-year oper-
ational plan is currently awaiting full endorsement by
national and international experts. Meanwhile, mass drug
administration (MDA) for schistosomiasis has com-
menced in 2013 with an initial emphasis on the Cavaly,
Guemon and Tonkpi regions in western Côte d’Ivoire
[25–27] and on the Agnéby region in south-eastern Côte
d’Ivoire [28]. Moreover, to better coordinate the control of
these diseases in Côte d’Ivoire, a national programme for
the control of neglected tropical diseases with preventive
chemotherapy (Programme National de Lutte contre les
Maladies Tropicales Négligées à Chimiothérapie Prévent-
ive; PNLMTN-CP) has been initiated in December 2016.
The programme is supported by the Schistosomiasis
Consortium for Operational Research and Evaluation
(SCORE) and the Schistosomiasis Control Initiative (SCI).
Operational research for schistosomiasis control in Côte
d’Ivoire
According to WHO, helminthiasis control programmes
should combine the administration of praziquantel against
Fig. 2 Climate diagrams (rainfall and temperature) in (a) northern
and (b) central Côte d’Ivoire. Adapted from climate-data.org [17]
(c) S. haematobium transmission dynamics in Tiengarakaha
(Ferkessedougou), in the northern part of Côte d’Ivoire. Comparison of
numbers of B. truncatus snails infected (left y-axis) and surviving
(right y-axis) collected from the lake of Tiengarakaha 30 days after the
maintenance of snails in the laboratory. Adapted from N’Goran [11]
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soil-transmitted helminthiasis, as these infections often
overlap geographically [29]. Wherever elimination of
schistosomiasis seems feasible, countries are encouraged
to change their control to an elimination strategy and to
provide praziquantel in intervals shorter than 12 months
and to complement with snail control and behaviour
change interventions, when applicable in order to inter-
rupt disease transmission [30].In line with WHO considerations to shift from
morbidity control to elimination of schistosomiasis as
a public health problem, the SCORE project described
here will focus on the interruption of S. haematobium
transmission. The study is carried out in the northern
and central parts of Côte d’Ivoire, where schisto-
somiasis transmission is seasonal. Specifically, we will
assess the impact of different interventions in four
study arms: (i) arm A: MDA before the peak transmission
season of schistosomiasis; (ii) arm B: annual MDA after
the peak schistosomiasis transmission season; (iii) arm C:
two yearly MDA treatments before and after the peak
schistosomiasis transmission; and (iv) arm D: annual
MDA before the peak schistosomiasis transmission,
coupled with tri-annual chemical snail control.
This is a 3-year randomised intervention study, pre-
ceded by one year of initial eligibility and baseline sur-
veys conducted in 2015, which allowed the selection of
60 study villages where interventions are implemented.
The impact of the interventions in each study arm will
be assessed in annual follow-up surveys carried out in
late 2016, late 2017 and late 2018.
The collaborative project involves teams from the Uni-
versité Félix Houphouët-Boigny (UFHB) and the Centre
Suisse de Recherches Scientifiques en Côte d’Ivoire
(CSRS; both based in Abidjan, Côte d’Ivoire), the Swiss
Tropical and Public Health Institute (Swiss TPH), an as-
sociated institute of the University of Basel; (Basel,
Switzerland) and the Natural History Museum (NHM;
London, United Kingdom). The project will be imple-
mented in close collaboration with the PNLMTN-CP
and linked to ongoing large-scale schistosomiasis control
efforts in the country, supported by SCI.Methods/design
Goal, aims and objectives
The goal of this SCORE study is to provide an evidence-
base for programme decisions about interrupting the
transmission of S. haematobium in a setting where trans-
mission is seasonal. In a cluster-randomised intervention
trial, we will determine whether different treatment
schemes can interrupt S. haematobium transmission and
whether soil-transmitted helminthiasis can be controlled.
The study will run for 3 years and includes one year of eli-
gibility and a detailed baseline survey. Each intervention
arm will include activities in 15 villages, hence a total of
60 communities.
The aims of the projects are (i) to interrupt seasonal
transmission of S. haematobium in pre-selected areas in
northern and central Côte d’Ivoire within 3 years of inter-
ventions; and (ii) to control soil-transmitted helminthiasis
in the same communities. There are four specific objec-
tives, activities and milestones, as follows:
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S. haematobium and soil-transmitted helminth
infections in communities (children and adults),
according to age and sex, and within and between
each study arm from year 1 to year 3;
 to determine the coverage and compliance
with annual or biannual MDA with praziquantel
for S. haematobium and albendazole for soil-
transmitted helminth infections;
 to assess the impact of chemical snail control
with niclosamide on the presence of Bulinus spp.
snails and on non-target fauna in freshwater
bodies; and
 to identify the different schistosome species of
cercaria shed by infected Bulinus spp. snails using
molecular methods.
Study setting
The study will be carried out in six administrative re-
gions of Côte d’Ivoire, four of which are located in the
north (Tchologo, Bounkani, Poro and Hambol) and two
in the centre of the country (Gbêkê and Bélier). These
regions have virtually the same climate and soil charac-
teristics. The Köppen-Geiger climate classification [31]
qualifies the climate of these regions as an “Aw type”;
hence, a tropical and dry or savannah climate. In northern
Côte d’Ivoire, the temperature ranges from 25 °C to 29 °C
(mean: 26.8 °C) and the monthly precipitation varies be-
tween 3 mm and 300 mm (annual mean: 1300 mm). In
the central part, the values are 24 °C to 27 °C (mean:
26.2 °C) and 11 mm to 200 mm (annual mean: 1100 mm),
respectively (https://fr.climate-data.org). The dry season
lasts from November to March, though a quite high rain-
fall is recorded in March in the central part of the country
(see Fig. 2a and b). Of note, in December and January, the
Harmattan – a strong dry wind from the Sahara – greatly
lowers the temperature, particularly at night. The soils are
mostly tropical ferruginous soils.
Population and primary economic activities
The Tchologo region is composed of three departments
and the Bounkani region is subdivided into four depart-
ments. The Poro region consists of four departments,
while the Hambol region has three departments. The
Gbêkê and Bélier regions have four departments each. In
those regions three quarters of the population are aged
below 40 years [32].
People are mainly engaged in subsistence farming (e.g.
maize, millet, sorghum and yam). The two main cash
crops are cotton and cashew. Moreover, there are some
irrigated rice farming and vegetable farming and fishing
activities in small multi-purpose dams, which were ini-
tially constructed for livestock breeding. Indeed, Tchologo
and Bounkani regions are suitable areas for livestockbreeding. During the dry season, there is a significant re-
duction of water sources and surfaces, but with some
remaining water points in the dams. This results in in-
creased contact of populations with these sites in the dry
periods, and hence, an increased risk of transmission of
water-related parasitic diseases such as schistosomiasis.
Justification of the number of clusters and participants
The selection of four intervention arms for this study
was based on equilibrium between what is scientifically
and technically recommended and what is practically
feasible during the eligibility and follow-up surveys. Sixty
study villages have been selected with 15 villages in each
of the four intervention arms. To assess the (baseline)
epidemiological situation of helminth infections in an
area, the WHO recommends sampling of at least 50
children in one school [3]. In the randomised interven-
tion trial, we aimed to include a total of 48,000 partici-
pants (i.e. 50 + 100 + 50 = 200 participants * 60 villages
* 4 surveys).
Eligibility of study communities and randomisation
Villages were eligible to be included into the study if
they fulfilled the following criteria:
 the village is located in an area with a well-defined
S. haematobium transmission season;
 there are at least 100 children aged 9–12 years
enrolled at school (determined by readily available
school lists); and
 the prevalence of S. haematobium is at least 4%, as
determined by a single mid-day urine filtration of 50
children aged 13–14 years in a prior eligibility
survey.
Once 60 eligible villages were identified, they were
randomly assigned to one of four intervention arms
(Fig. 3):
 arm A: annual MDA with praziquantel and
albendazole before the peak transmission season of
schistosomiasis (November/December);
 arm B: annual MDA with praziquantel and
albendazole after the peak transmission season of
schistosomiasis (March/April);
 arm C: two yearly MDAs before and after the peak
transmission of schistosomiasis (November/
December and March/April); and
 arm D: annual MDA with praziquantel and
albendazole before the peak transmission season of
schistosomiasis (November/December), coupled
with chemical snail control using niclosamide (three
applications per year: before, during and shortly
after the peak transmission).
Fig. 3 Cluster randomised intervention trial with four intervention arms. The study will be implemented over a 3-year period, and hence, the
interventions specified here will be repeated every year. MDA, mass drug administration; Holiday, no intervention; Msc, mollusciciding
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To identify 60 eligible study communities, we pursued a
two-stage approach, making use of the existing educa-
tion system. A pre-screening for potential study villages
was conducted by applying a rapid-assessment question-
naire for the presence of blood in urine that served as a
proxy for S. haematobium infection. Of note, this ques-
tionnaire has previously been validated in Côte d’Ivoire
[33]. Teachers from the study regions were invited to
interview children attending grades 3–5. The schools
with a S. haematobium prevalence above 4% of reported
blood in urine during the 2 weeks preceding the ques-
tionnaire were selected for further investigation. In eli-
gible schools, 50 children aged 13–14 years were
randomly selected and invited to provide a single mid-
day urine sample. The urine samples were processed by
a filtration method for detection of S. haematobium
eggs [34]. In addition, urine samples were subjected to
reagent strip testing for microhaematuria (a proxy for
S. haematobium infection) [35] and a point-of-care cir-
culating cathodic antigen (POC-CCA) cassette test for
the diagnosis of S. mansoni [36]. Once 60 villages with
a prevalence of S. haematobium ≥ 4%, based on urine
filtration, were identified, they were included in the
study and randomised to one of four study arms.
Parasitological surveys
During the baseline survey prior to any intervention
and at annual cross-sectional surveys conducted over a
3-year period, single urine and stool samples will be
collected from 50 children aged 5–8 years, 100 children
aged 9–12 years and 50 adults aged 20–55 years in each
of the 60 study villages. A mid-day urine specimen
(at least 20 ml) and an early morning stool sample willbe collected from each participant. Urine and stool
samples will be examined in the laboratory at the dis-
trict health centre.
Examination of urine and stool samples
In the laboratory, each urine sample will be tested for the
presence of haematuria (visual detection for macrohaema-
turia and reagent strip testing for microhaematuria) [37].
S. haematobium eggs will be quantified by urine filtration
(10 ml urine) under a microscope [37, 38]. Two micro-
scope slides will be prepared per stool sample using the
Kato-Katz technique [39]. To this end, thick smears will
be prepared from each sample using standard 41.7 mg
templates. The slides will be examined under a micro-
scope as soon as prepared for the detection of hookworm
eggs and a second time after clearing of at least 45 min
for the detection of other soil-transmitted helminths
and S. mansoni. Helminth eggs will be counted and
recorded for each species separately [25].
MDA and tracking compliance
Two MDA approaches will be used: school-based treat-
ment (SBT) and community-wide treatment (CWT).
Praziquantel and albendazole will be provided as a single
oral dose of 40 mg/kg and 400 mg, respectively, accord-
ing to the schedules defined for the different study arms.
School teachers and community-drug distributors (CDDs)
will deliver the drugs to the children and the community
members, respectively. Medical staff will check for exclu-
sion criteria (e.g. hypersensitivity to praziquantel or alben-
dazole, pregnancy among female participants). In all arms
of the study, praziquantel will also be provided to health
centres for the management of all cases detected during
routine consultations.
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CDDs who will deliver the drug to the children and the
community members, respectively, will fill in separate
treatment records. The treatment reports from teachers
and CDDs will be compiled by the local principal inves-
tigator. Tracking schoolchildren will be facilitated
through the education system. With regard to school-
aged children not attending school and the rest of the
community, we will adopt a household approach to offer
everyone a “health record”, which will include a unique
identifier, the person’s name, age, sex and three open
boxes corresponding to 3 years of follow-up. In the latter
approach, CDDs will assist with the treatment of adults
and school-aged children not attending school. CDDs will
be trained to record the aforementioned information for
community members. Records will remain confidential.
Of note, some of the praziquantel and albendazole
stock will be kept at the health centre, in order that
CDDs will be able to treat members in the community
who did not receive the treatment.
Response to treatment and reporting of adverse events
Treatment will be administered by trained teachers dur-
ing SBT or CDDs during CWT. Adverse events will be
monitored by the physicians and nurses of the local
health facilities. Individuals who received praziquantel
will be invited to report to these first-line centres in case
of any adverse events after drug administration (“any-
thing abnormal occurring in your body”). The health
centre personnel will be trained on how to fill in the
standard record forms (adopting a grading score) and
instructed to refer to second-line hospitals any individ-
ual presenting with severe adverse events that they could
not manage. Both passive and active surveillance mea-
sures will be implemented during the MDA intervention.
Passive measures will be aimed at ensuring rapid med-
ical assistance for any individuals who might experience
adverse events after treatment, while active measures
will also be in place to elucidate the nature, frequency
and severity of adverse events.
Passive measures will be established on the treatment day
and the day after; one or two health centres at the district
will be kept open for 24 h and equipped with first-line
emergency drugs (i.e. non-steroid anti-inflammatory drugs,
anti-histaminic drugs, cortisone and intravenous fluids).
Information, education and communication (IEC)
campaign
In close collaboration with the national control
programme, IEC materials (e.g. posters, pamphlets, flip
charts and calendars) will be introduced during commu-
nity and school mobilization sessions addressed to CDDs,
teachers and community members by teams formed by
the principal investigators and co-investigators.Training of teachers and others who will administer
praziquantel and albendazole
Training programmes for two teachers and two CDDs in
each community (hence, a total of 120 teachers and 120
CDDs) will be developed in order to standardise the
intervention (i.e. SBT and CWT). Such training will
focus on basic principles of IEC, while it will provide
teachers and CDDs with a basic understanding of schis-
tosomiasis and how to administer praziquantel and
albendazole and fill-in the forms. These sessions will be
delivered jointly by the health personnel and the re-
search team.
Approaches for reaching school-aged children not attend-
ing school
With regard to the non-enrolled school-aged children,
we will adhere to an approach successfully piloted in
Zanzibar, where all attending schoolchildren were en-
couraged to inform and bring along their non-enrolled
siblings and other non-attending children from the village
to the school for free treatment provided at a specific
treatment day [40]. Additionally, CDDs will implement a
door-to-door treatment visit in order to enhance the
coverage rate of non-enrolled schoolchildren and reluc-
tant adults. Additionally, praziquantel and albendazole will
be made available at health centres.
Process measures that will be collected
We will collect the following process measures:
 number of treatments delivered against
schistosomiasis and soil-transmitted helminthiasis,
by whom and whether SBT, CWT or health
facility-based;
 number of teachers and CDDs trained;
 number of sessions of community education, who
delivered them and how many people participated;
 number of returned reports from distributors/
teachers and completeness and other quality
measures;
 knowledge of schistosomiasis and soil-transmitted
helminthiasis, source of knowledge, opinion about
treatment campaign from children and adults in-
cluded in the studies; and
 knowledge of schistosomiasis and soil-transmitted
helminthiasis, source of knowledge, opinion about
treatment campaign from volunteer teachers and
CDDs involved in the corresponding interventions
and technical questions with regards to their training.
Coverage assessment and actions taken in case of low
treatment coverage
In 2014, a general national census (GNC) has been con-
ducted to update the demographic data of Côte d’Ivoire
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study area from this census have been sought from local
authorities. This database served as a reference for the
calculation of treatment coverage rate. In brief, we will
divide the number of treated individuals by the number
of eligible school-aged children and adults living in a
given village. We assume that among school-aged chil-
dren, an acceptable coverage might be at least 85%. In
adults the target coverage might be considerably lower,
and in our view an acceptable coverage might be set at a
level of 75%. If these coverage rates are not reached dur-
ing the treatment campaign, we will intensify sensitisa-
tion on three levels, namely (i) community-directed; (ii)
health centre-based; and (iii) school-based, and repeat
the treatment campaign. In addition, meetings will be
held in all study villages with local authorities. In par-
ticular, village leaders (i.e. village chiefs, leaders of youth
and women’s groups) will be invited to assist with
setting-specific activities in order to boost coverage
rates.
Snail control, the status of niclosamide at the study site
and concerns about its use
Niclosamide is the main molluscicide registered and rec-
ommended by WHO [41], and it has been widely used
in the past in different contexts and countries, notably
on the African continent. Currently, it is used for the
control of schistosomiasis intermediate host snails in the
People’s Republic of China [42], Tunisia [43], Morocco
[44], Egypt [45] and the United Republic of Tanzania
(Zanzibar) [37]. To our knowledge, although niclosamide
is registered in Côte d’Ivoire as a drug for human use,
there is no prior experience with the use of niclosamide
as molluscicide in the country. Under these circum-
stances, approval for exceptional use in the frame of the
current research project has been sought and granted
from the national committee for pesticide use (Comité
Pesticides de Côte d’Ivoire, Ministère de l’Agriculture;
approval no. 0163; date of approval 27 January 2015).
Additionally, the field implementation will be supervised
by experts from NHM in London, who currently are in-
volved in mollusciciding activities in the frame of the
Zanzibar Elimination of Schistosomiasis Transmission
(ZEST) project [46]. An important issue will be to care-
fully document potential negative impacts of the intro-
duction of niclosamide on non-targeted fauna in the
intervention villages. Côte d’Ivoire has proven skills in
vector management, i.e. larviciding of rivers against
blackfly larvae (vector of onchocerciasis).
Snail control will be implemented in one of the inter-
vention arms, hence in 15 of the 60 study villages. Snail
species will be located and characterised within trans-
mission sites. In each selected community, approxi-
mately three sites will be surveyed.Once the randomisation of the villages has been done,
a baseline malacological survey will be conducted in the
surroundings of the 15 target villages, thus allowing a
more detailed study on schistosomiasis transmission at
sites where potential intermediate host snails occur.
After the baseline malacological survey, a first focal
treatment with niclosamide (concentration of 10 g/l)
will be undertaken at water contact sites found to be
infested with Bulinus spp. (B. truncatus and/or B. glo-
bosus). In order to monitor the population dynamics
of non-target aquatic organisms over time, an inven-
tory focussing on species and abundances will be con-
ducted before the intervention and at each following
malacological survey. Members of the study team will
be trained on the different application techniques of
molluscicides. Based on available information on
transmission and climate of the study area, mollusci-
ciding interventions are planned three times a year:
before and after the main rainy season and in the
middle of the dry season. The coordination of the
timely MDA and the mollusciciding activities are cru-
cial to increase the impact on snail control and vice
versa. In this respect, each year the mollusciciding
will be carried out before or during the MDA.
Additionally, the status of snail infection by Schis-
tosoma spp. will be tested with the cercarial shed-
ding method and by molecular characterisation of
schistosome species in snails. This characterisation
will be carried out at NHM during year 2 of the
study. The aim is to gain a deeper insight on the
snail species involved in local S. haematobium trans-
mission and on potential other schistosome species
endemic in the region. In fact, it is conceivable that
S. bovis and other intestinal parasites, usually found
in livestock, are endemic in this zone where pastor-
alism is common.
Assessment of transmission foci and intensity
Water contact sites used by community members in
each village will be identified and georeferenced using
hand-held global positioning system (GPS; Garmin Sery
GPS MAP 62; Olathe, United States of America) devices.
For the identification of water contact sites, where trans-
mission can occur, school-aged children, who have been
identified as S. haematobium-positive, will show our
team the sites where they get in contact with water for
recreational or domestic activities. Additionally, we will
collect relevant information of water contact from com-
munity leaders.
Once the sites have been identified, they will be
searched for intermediate host snails by four experi-
enced fieldworkers, adhering to standard protocols (i.e.
15 min of sampling in a predefined area using a mesh
scoop, constructed of kitchen sieves mounted on a 1.5 m
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using scoops and forceps. Although this method has
some limitations (e.g. ineffectiveness at sites with diffi-
cult access and the subjectivity of the investigator), it has
the advantage of being simple and represents a minimal
intrusion on the environment.
This process will be implemented in each study
village three times, just before niclosamide is applied
(i.e. before and after the rainy season and in the middle
of the dry season). Snails sampled at individual sites
will be stored in containers filled with water from the
originating site and transferred to a laboratory at the
UFHB in Abidjan. Snails will be kept at room
temperature (24–27 °C). The containers will be labelled
with unique identifiers. In the laboratory, snails will be
kept alive in covered water tanks at room temperature,
using water from the original site. Snail species will be
identified from shell morphology.
To assess the transmission level, cercarial shedding
will be observed over the first 48 h after collection.
All Bulinus spp. found will be individually inspected
for infection by placing snails into 12 or 24 well
plates and exposed to sunlight or artificial light for 3
to 6 h and subsequently be examined under a dissec-
tion microscope for the presence of Schistosoma cer-
caria [47]. If present, a subsample of 20–30 cercariae
will be collected individually onto a Whatman FTA
card (GE Healthcare Life Sciences; Amersham, United
Kingdom) and sent to the NHM for molecular
analysis.
Additionally, a subsample of snails (up to 50 snails
per site) will be fixed in ethanol and forwarded to the
Schistosomiasis Collection at the NHM in London
(SCAN) for molecular diagnosis [48].
Study outcomes
Analysis plan to assess outcomes of interest
In addition to parasitological data, demographic data
(age, sex and occupation for adults) will be recorded
from each participant. Changes in the S. haematobium
and soil-transmitted helminth infection prevalence and
intensity will be assessed for each intervention arm over
time. The treatment coverage rates among children and
adults will be estimated by dividing the number of par-
ticipants of the respective age group treated by the total
number of registered individuals of the corresponding
age range in the community. Adverse events and serious
adverse events will be tracked and recorded for manage-
ment. Community sensitisation and mobilisation efforts,
radio announcements and other IEC tools will be used
to help enhancing reach-out to populations targeted for
treatment in the MDA. Moreover, we will make efforts
to record any major change in water, sanitation and hy-
giene (WASH), unusual weather (e.g. drought andfloods), political instability or local changes in leadership
that might affect MDA efforts, changes in the existing
health system, community attitudes and behaviour related
to health and health care seeking and other programmes
(e.g. IEC or WASH) that are introduced during the study
period.
All parasitological data will be double-entered and
cross-checked by experienced data entry clerks
employed at CSRS. Statistical analyses will be carried
out using EpiInfo version 3.5 (Centers for Disease Con-
trol and Prevention; Atlanta, United States of America)
and STATA version 10 (Stata Corp.; College Station,
United States of America). The primary outcome will be
the change in prevalence and intensity of S. haemato-
bium infection in each of the four study population
groups over the 3 years of the study. Each year, S. hae-
matobium prevalence and infection intensity data will be
calculated. The results from the different study arms will
be compared on an annual basis and at the end of the 3-
year intervention period. The snail abundance and infec-
tion rates over time will allow us to draw inference on
the force of transmission. Moreover, the overall impact
of the different treatment schemes on soil-transmitted
helminthiasis will be measured in terms of prevalence
and intensity of infection.
Minimise bias
There are a host of factors that could affect the out-
comes, including political instability as experienced in
our previous and still ongoing SCORE-funded research
[24]. However, our team is well prepared for such issues.
Maintaining good communication among the partners
and the national schistosomiasis control programme,
local authorities and the SCORE secretariat will minim-
ise potential negative outcomes.
Protocol review and ethical clearance
The study protocol has been approved by the institu-
tional research commissions of CSRS in Abidjan and
Swiss TPH in Basel. Ethical approval was obtained from
the ethics committees in Switzerland: “Ethikkommission
Nordwest- und Zentralschweiz (EKNZ)” (reference no.
UBE-15/34; date of approval 15 April 2015) and in Côte
d’Ivoire: Comité National d’Éthique et de la Recherche,
Ministère de la Santé et de Lutte contre le SIDA (refer-
ence no. 007/MSLS/CNER-kp; date of approval 2 Febru-
ary 2016) and Direction Générale des Productions et de
la Sécurité Alimentaire, Ministère de l’Agriculture,
(reference no. 0163/MINAGRI/DGPSA/DPVCQ; date of
approval 27 January 2015). The trial is registered at the
International Standard Randomised Controlled Trial
Number (ISCRCTN) Register (ISRCTN10926858; http://
www.controlled-trials.com/ISRCTN10926858; date of
registration 21 December 2016).
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and parents or legal guardians of children below the age
of 18 years. Children aged between 5 and 18 years will
sign an informed assent form. Participation is voluntary
and study participants have the right to withdraw from
the study at any given point in time with no further
obligations.
The results of this study might be published, but the
names of subjects or their identities will not be revealed.
Records will remain confidential and will be stored in a
secured locker. The results of tests will be coded to pre-
vent association with participants’ names. The investiga-
tors will keep a separate confidential enrolment log that
matches identifying codes with the subjects’ names. Only
authorized personnel directly involved in the study
will have access to data entered into computerized
files and encoded. Subject-specific information may be
provided to medical personnel only with the subject’s
permission.
Depending on the intervention arm, subjects will be
treated free of charge once or twice a year with praziquantel
(40 mg/kg) using a dose-pole [9, 49] and with a single dose
of albendazole (400 mg). Adverse events will be monitored
and recorded as detailed before. Of note, praziquantel and
albendazole are considered safe and well-tolerated drugs,
which are annually distributed to millions of people in en-
demic countries during MDA campaigns in line with
WHO guidelines. In Côte d’Ivoire, such treatment cam-
paigns have been commenced by the PNLMTN-CP,
which is also in charge of the MDA in the frame of this
project. No potential risk is linked to participation in
the project as the collected samples are limited to stool
and urine.
Discussion
In some regions of Côte d’Ivoire, elimination of schisto-
somiasis seems feasible, due to a strong seasonality of
the disease transmission. In line with WHO recommen-
dations published in 2012 [30], the country now aims to
interrupt the transmission of S. haematobium infections
in some selected areas in the central and northern re-
gions. Our study will reveal whether or not urogenital
schistosomiasis transmission can indeed be interrupted
in the targeted areas in northern and central parts of
Côte d’Ivoire with a package of well-tailored and fo-
cussed interventions implemented over a 3-year period.
It will also show whether it is feasible to control soil-
transmitted helminthiasis as a public health problem in
the targeted areas. Finally, it will elucidate whether an-
nual MDA with praziquantel and albendazole before the
peak transmission season of urogenital schistosomiasis
(arm A) or annual MDA with praziquantel and albenda-
zole after the peak transmission season of schistosomiasis
(arm B) are sufficient measures to interrupt transmissionof urogenital schistosomiasis or whether intensified
interventions such as two yearly MDAs before and
after the peak schistosomiasis transmission (arm C) or an-
nual MDA with praziquantel and albendazole before the
peak schistosomiasis transmission season, coupled with
chemical snail control using niclosamide (arm D) are
needed to break transmission.
As several cases of reinfection with S. haematobium
following exclusive chemotherapy have been reported in
Côte d’Ivoire [50, 51] and elsewhere [52–54], we hy-
pothesise that MDA timed with chemical snail control
with niclosamide will be the best measure for elimin-
ation of urogenital schistosomiasis transmission. If con-
firmed in our study, this approach might be adopted by
the PNLMTN-CP in its strategic plan for controlling
and eliminating schistosomiasis from Côte d’Ivoire in
the next several years. Of note, MDA plus snail control
has been shown to contribute to the interruption of schis-
tosomiasis transmission in other countries [20, 55, 56].
This approach is currently being applied, and its impact
assessed, in a multi-year project to eliminate urogenital
schistosomiasis transmission on the Zanzibar archipelago
[37, 46]. While there is no evidence about tolerance or re-
sistance to niclosamide in snails thus far [57, 58], intensive
application of niclosamide will require careful monitoring
of snails and other non-target fauna.
The study on interrupting seasonal transmission of uro-
genital schistosomiasis and control of soil-transmitted hel-
minthiasis described here will provide an evidence-base
for future programme decisions for an informed choice
between exclusive schemes of MDA (according to the type
and frequency) and MDA combined with chemical snail
control for interrupting seasonal transmission of uro-
genital schistosomiasis in areas with marked seasonality as
found in northern and central parts of Côte d’Ivoire. With
this new insight into disease elimination approaches, the
study will help to improve guidelines for neglected
tropical disease control and elimination programmes and
decision makers in Côte d’Ivoire and in other endemic
countries.
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